Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Institute of Nanotechnology Announces Second Annual Investing in Medical Nanotechnology conference and exhibition

Abstract:
Building on the success of 'Investing in Medical Nanotechnologies-2006', the Institute of Nanotechnology, a global leader in nanotechnology information services and technology transfer in partnership with Nanomednet, the nanomedicine network for medical professionals, industry and investors, announces the second annual conference and exhibition, 'Investing in Medical Nanotechnology 2' to be held at Royal College of Surgeons of England, London on 28-29 November, 2007.

Institute of Nanotechnology Announces Second Annual Investing in Medical Nanotechnology conference and exhibition

London, UK | Posted on May 28th, 2007

Attended by major industrial players, start-ups, investors, business analysts and consultants, this two-day conference promises to spotlight cutting-edge technologies and routes to finance. The associated exhibition will showcase novel nanotechnologies in clinical applications. The European nanotech community will gather for two days to discuss the latest applications of nanotechnology in Tissue Engineering and Regenerative Medicine, Drug Delivery and Pharmaceutical Development as well as Novel Devices, Nanosensors and Diagnostics. Small companies will pitch their novel innovations to investors and potential customers seeking support and partnerships.
The conference has already lined up a list of eminent speakers including Prof. Dr. J.W. Hans Hofstraat, Vice President, Healthcare Strategic Partnerships, Philips Research, Dr. John Baldoni, Senior Vice President of Pharmaceutical Development, GlaxoSmithKline, Mr. Michel Lussier, Vice President, General Manager, Volcano Corp., Prof. Jörg Vienken, Vice-President, BioScience Department, Fresenius Medical Care, Mr. Robert Jelski, Sector Partner, Electronics, Semiconductors & Advanced Technologies,3i,Dr. Renzo Tomellini, Head of Nanotechnology Unit, European Commission, Prof. Seeram Ramakrishna, Dean of the Faculty of Engineering, National University of Singapore, Prof. Amarnath Maitra, Dept. of Chemistry, University of Delhi and many small companies.
The conference also offers an opportunity to the delegates to showcase their technology and services to potential partners, investors and customers through posters. This complimentary service to all the delegates will add more value to the event by bringing together maximum number of novel ideas in minimum time. In addition to this, there are opportunities available for industry and academia to display their innovations through limited exhibition spaces.

For more information on sponsorship, poster display and exhibition opportunities; contact Tiju Joseph at The Institute of Nanotechnology on +44 (0) 141 330 8734, EMail: , website: http://www.nanomednet.org/conference07

####

About Institute of Nanotechnology
The Institute of Nanotechnology is a charitable organization created to foster, develop and promote all aspects of science and technology in those domains where dimensions and tolerances in the range of 0.1 nm to 100nm play a critical role.

For more information, please click here

Contacts:
Tiju Joseph
The Institute of Nanotechnology
+44 (0) 141 330 8734

Copyright © Institute of Nanotechnology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Events/Classes

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project